Trademarkia Logo

Canada

C$
ENRIAV DESIGN
REGISTERED

on 8 Nov 2019

Last Applicant/ Owned by

DAIICHI SANKYO COMPANY LIMITED

3-5-1, Nihonbashi Honcho, Chuo-ku, Tokyo 103-8426,

JP

Serial Number

1811244 filed on 25th Nov 2016

Registration Number

TMA1062447 registered on 8th Nov 2019

Registration expiry Date

8th Nov 2029

Correspondent Address

MARKS & CLERK

180 Kent StreetSuite 1900Ottawa

ONTARIO

CA

K1P0B6

ENRIAV DESIGN

Trademark usage description

pharmaceutical preparations for the treatment and prevention of cardiovascular disease, atherosclerosis, diabetic nephropathy, stroke, heart attack, h Read More

Classification Information


Class [005]
Pharmaceutical preparations for the treatment and prevention of cardiovascular disease, atherosclerosis, diabetic nephropathy, stroke, heart attack, hypercholesterolemia, dyslipidemia, anemia, blood disorders, diabetes, thyroid function disease, cancer, oncological disease, metastasis, autoimmune disease, allergy, bacterial infection of skin, soft tissue, spinal cord, endocrine, respiratory, and central nervous system, viral infection of skin, soft tissue, spinal cord, endocrine, respiratory, and central nervous system, fungal infection, inflammation, namely, anti-inflammatories, osteoporosis, Alzheimer's disease, obesity, anorexia, urinary and kidney disease, respiratory disease, gastrointestinal disease; pharmaceutical preparations for the relief of pain; pharmaceutical preparations in the form of vaccines for the prevention and treatment of infectious diseases, namely, influenza vaccines, diphtheria vaccines, tetanus vaccines, gas gangrene vaccines, Japanese encephalitis vaccines, measles vaccines, rubella vaccines, parotitis vaccines, pertussis vaccines, poliomyelitis vaccines and the above combined vaccines; pharmaceutical preparations for the treatment and prevention of musculoskeletal disorders, namely connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations, namely diagnostic contrast agents for ultrasound imaging, X-ray imaging, magnetic resonance imaging, nuclear imaging, namely scintigraphy, isotope, radioisotope, gamma camera, Positron Emission Tomography (PET), tactile imaging, photoacoustic imaging, tomography, echocardiography imaging, functional near-infrared spectroscopy imaging, magnetic particle imaging.


Classification kind code

10

Mark Details


Serial Number

1811244

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 50
on 14th Dec 2018
Allowed
Submitted for opposition 51
on 14th Dec 2018
Allowance Notice Sent
Submitted for opposition 42
on 29th Aug 2018
Advertised
Submitted for opposition 26
on 9th Aug 2018
Approved
Submitted for opposition 27
on 19th Jun 2018
Approval Notice Sent
Submitted for opposition 22
on 5th Sept 2017
Search Recorded
Submitted for opposition 20
on 5th Sept 2017
Examiner's First Report
Submitted for opposition 1
on 28th Nov 2016
Created
Submitted for opposition 31
on 28th Nov 2016
Formalized
Submitted for opposition 30
on 25th Nov 2016
Filed